|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bejerano G, Pheasant M, Makunin I, Stephen
S, Kent WJ, Mattick JS and Haussler D: Ultraconserved elements in
the human genome. Science. 304:1321–1325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mestdagh P, Fredlund E, Pattyn F, Rihani
A, Van Maerken T, Vermeulen J, Kumps C, Menten B, De Preter K,
Schramm A, et al: An integrative genomics screen uncovers ncRNA
T-UCR functions in neuroblastoma tumours. Oncogene. 29:3583–3592.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA, Liu CG, Ferracin M, Hyslop T,
Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et
al: Ultraconserved regions encoding ncRNAs are altered in human
leukemias and carcinomas. Cancer Cell. 12:215–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sana J, Hankeova S, Svoboda M, Kiss I,
Vyzula R and Slaby O: Expression levels of transcribed
ultraconserved regions uc.73 and uc.388 are altered in colorectal
cancer. Oncology. 82:114–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hudson RS, Yi M, Volfovsky N, Prueitt RL,
Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K,
Stephens RM, et al: Transcription signatures encoded by
ultraconserved genomic regions in human prostate cancer. Mol
Cancer. 12:132013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Braconi C, Valeri N, Kogure T, Gasparini
P, Huang N, Nuovo GJ, Terracciano L, Croce CM and Patel T:
Expression and functional role of a transcribed noncoding RNA with
an ultraconserved element in hepatocellular carcinoma. Proc Natl
Acad Sci USA. 108:786–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bo C, Li N, Li X, Liang X and An Y: Long
noncoding RNA uc.338 promotes cell proliferation through
association with BMI1 in hepatocellular carcinoma. Hum Cell.
29:141–147. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin W, Chen L, Cai X, Zhang Y, Zhang J, Ma
D, Cai X, Fu T, Yu Z, Yu F and Chen G: Long non-coding RNA TUC338
is functionally involved in sorafenib-sensitized hepatocarcinoma
cells by targeting RASAL1. Oncol Rep. 37:273–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Q, Shen F and Wang C: TUC338 promotes
cell migration and invasion by targeting TIMP1 in cervical cancer.
Oncol Lett. 13:4526–4532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao X, Gao X, Li C, Zhang Y and Gao L:
Knockdown of long noncoding RNA uc.338 by siRNA inhibits cellular
migration and invasion in human lung cancer cells. Oncol Res.
24:337–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang C, Wang Z, Zhou J, Liu S, Wu C, Huang
C and Ding Y: TUC.338 promotes invasion and metastasis in
colorectal cancer. Int J Cancer. 140:1457–1464. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Catucci I, Verderio P, Pizzamiglio S,
Manoukian S, Peissel B, Barile M, Tizzoni L, Bernard L, Ravagnani
F, Galastri L, et al: SNPs in ultraconserved elements and familial
breast cancer risk. Carcinogenesis. 30:544–545; author reply 546.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bao BY, Lin VC, Yu CC, Yin HL, Chang TY,
Lu TL, Lee HZ, Pao JB, Huang CY and Huang SP: Genetic variants in
ultraconserved regions associate with prostate cancer recurrence
and survival. Sci Rep. 6:221242016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen H, Lu C, Jiang Y, Tang J, Chen W,
Zhang H, Zhang Q, Wang J, Liang J, Hu Z and Shen H: Genetic
variants in ultraconserved elements and risk of breast cancer in
chinese population. Breast Cancer Res Treat. 128:855–861. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng JC, Shen J and Ran ZH: Transcribed
ultraconserved region in human cancers. RNA Biol. 10:1771–1777.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Motokura T and Arnold A: Cyclin D and
oncogenesis. Curr Opin Genet Dev. 3:5–10. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pines J: Cyclins: Wheels within wheels.
Cell Growth Differ. 2:305–310. 1991.PubMed/NCBI
|
|
21
|
Niculescu AB III, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S
and the G2/M cell cycle transitions: PRb is a critical determinant
in blocking DNA replication and in preventing endoreduplication.
Mol Cell Biol. 18:629–643. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abbas T and Dutta A: p21 in cancer:
Intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Casimiro MC and Pestell RG: Cyclin d1
induces chromosomal instability. Oncotarget. 3:224–225.
2012.PubMed/NCBI
|
|
25
|
Leontieva OV, Lenzo F, Demidenko ZN and
Blagosklonny MV: Hyper-mitogenic drive coexists with mitotic
incompetence in senescent cells. Cell Cycle. 11:4642–4649. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang
J, Fu M, Leader JE, Quong A, Novikoff PM and Pestell RG: Cyclin D1
repression of nuclear respiratory factor 1 integrates nuclear DNA
synthesis and mitochondrial function. Proc Natl Acad Sci USA.
103:11567–11572. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen J, Zhao KN, Li R, Shao R and Chen C:
Activation of PI3K/Akt/mTOR pathway and dual inhibitors of PI3K and
mTOR in endometrial cancer. Curr Med Chem. 21:3070–3080. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee JJ, Loh K and Yap YS: PI3K/Akt/mTOR
inhibitors in breast cancer. Cancer Biol Med. 12:342–354.
2015.PubMed/NCBI
|
|
29
|
Wang L, Cao XX, Chen Q, Zhu TF, Zhu HG and
Zheng L: DIXDC1 targets p21 and cyclin D1 via PI3K pathway
activation to promote colon cancer cell proliferation. Cancer Sci.
100:1801–1808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan L and Shi G: Effect of IFN-α on
hepatic cancer SMCC-7721 cell via PI3K/Akt signaling pathway and
related mechanism research. Zhonghua Yi Xue Za Zhi. 95:2960–2963.
2015.(In Chinese). PubMed/NCBI
|
|
31
|
Liu J, Zhang C, Hu W and Feng Z: Tumor
suppressor p53 and its mutants in cancer metabolism. Cancer Lett.
356:197–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Zhang C and Feng Z: Tumor
suppressor p53 and its gain-of-function mutants in cancer. Acta
Biochim Biophys Sin (Shanghai). 46:170–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duffy MJ, Synnott NC, McGowan PM, Crown J,
O'Connor D and Gallagher WM: p53 as a target for the treatment of
cancer. Cancer Treat Rev. 40:1153–1160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Muller PA, Caswell PT, Doyle B, Iwanicki
MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL,
Gosselin P, et al: Mutant p53 drives invasion by promoting integrin
recycling. Cell. 139:1327–1341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hanel W, Marchenko N, Xu S, Yu SX, Weng W
and Moll U: Two hot spot mutant p53 mouse models display
differential gain of function in tumorigenesis. Cell Death Differ.
20:898–909. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Riley T, Sontag E, Chen P and Levine A:
Transcriptional control of human p53-regulated genes. Nat Rev Mol
Cell Biol. 9:402–412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Haupt S, Berger M, Goldberg Z and Haupt Y:
Apoptosis-the p53 network. J Cell Sci. 116:4077–4085. 2003.
View Article : Google Scholar : PubMed/NCBI
|
